| Bioactivity | MO-I-500 is a pharmacological of FTO inhibitor with an IC50 of 8.7 μM for the inhibition of purified FTO demethylase catalyzing demethylation of an artificial small methylated substrate. MO-I-500 can be used for the research of rare panresistant triple-negative inflammatory breast cancer[1]. |
| Name | MO-I-500 |
| CAS | 1585219-04-0 |
| Formula | C12H12ClNO5S |
| Molar Mass | 317.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Balraj Singh et al. Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge. PLoS One. 2016 Jul 8;11(7):e0159072. |
MO-I-500
CAS: 1585219-04-0 F: C12H12ClNO5S W: 317.75
MO-I-500 is a pharmacological of FTO inhibitor with an IC50 of 8.7 μM for the inhibition of purified FTO demethylase ca
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.